The Second Generation of COX-2 Inhibitors: What Advantages Do the Newest Offer?

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.1, 2003-01, pp. : 33-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aldosterone Receptor Antagonists for Hypertension: What Do They Offer?

By Liew D. Krum H.

Drugs, Vol. 63, Iss. 19, 2003-01 ,pp. : 1963-1972

Adis International

Access to resources Recommend Favorite

COX-2 Selective Nonsteroidal Anti-Inflammatory Drugs: Do They Really Offer Any Advantages?

By Jackson L.M. Hawkey C.J.

Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. : 1207-1216

Adis International

Access to resources Recommend Favorite

Combination Pharmacotherapy for Stopping Smoking: What Advantages Does it Offer?

By Ebbert Jon O. Hays J. Taylor Hurt Richard D.

Drugs, Vol. 70, Iss. 6, 2010-04 ,pp. : 643-650

Adis International

Access to resources Recommend Favorite

Third-Generation Antidepressants: Do They Offer Advantages Over the SSRIs?

By Olver J.S. Burrows G.D. Norman T.R.

CNS Drugs, Vol. 15, Iss. 12, 2001-01 ,pp. : 941-954

Adis International

Access to resources Recommend Favorite

Combined Opioid-NMDA Antagonist Therapies: What Advantages Do They Offer for the Control of Pain Syndromes?

By Wiesenfeld-Hallin Z.

Drugs, Vol. 55, Iss. 1, 1998-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite